Ligand validation:6QWC

MK7: (2S,5R)-1-formyl-N-(piperidin-4-yl)-5-[(sulfooxy)amino]piperidine-2-carboxamide

MK7 is a Ligand Of Interest in 6QWC designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6QWC_MK7_A_310	93%	36%	0.08	0.974	1.54	1	4	-	3	0	100%	0.93
6QWB_MK7_A_307	99%	23%	0.064	0.994	1.69	1.48	3	3	7	0	100%	0.35
6QW9_MK7_A_305	96%	35%	0.075	0.986	1.38	1.17	2	2	1	0	100%	0.65
6QWA_MK7_A_305	92%	35%	0.091	0.983	1.43	1.13	2	2	2	0	100%	0.67
8EHH_MK7_A_301	82%	32%	0.099	0.953	1.2	1.47	2	3	0	0	100%	1
4NK3_MK7_A_401	71%	33%	0.088	0.907	1.09	1.54	1	5	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.